A final order has been issued by the Ontario Superior Court of Justice approving Stryker's acquisition of fluorescence imaging technology maker Novadaq Technologies, valued at $700 million. The completion of the deal is still subject to approvals from US and Canadian antitrust regulators.
Stryker's $700M acquisition of Novadaq gains approval from Canadian court
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.